TheProfitWatch

KNSA - Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
42.31 -0.51 (-1.21%) -0.07 (-0.17%) -0.08 (-0.19%) -0.17 (-0.41%) 0.0 (0.0%) 0.58 (1.41%) --- 0.0 (0.0%)

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.24
Diluted EPS:
0.23
Basic P/E:
174.1667
Diluted P/E:
181.7391
RSI(14) 1m:
52.75
VWAP:
41.83
RVol:

Events

Period Kind Movement Occurred At

Related News